Does Gateway Health Plan Cover Cialis?

Gateway Health Plan and UPMC: Understanding the Merger

Gateway Health Plan was a Pennsylvania-based Medicaid and Medicare managed care organization serving hundreds of thousands of members. In 2019, UPMC Health Plan completed its acquisition of Gateway Health Plan, folding Gateway's membership into the broader UPMC insurance network [1]. This matters for prescription coverage because formulary decisions now flow through UPMC Health Plan's pharmacy benefit management structure.

What the Merger Means for Your Formulary

If you enrolled through Gateway Health Plan, your drug formulary is now maintained by UPMC Health Plan. Formulary updates occur quarterly, and the most current drug list is published on the UPMC Health Plan member portal. The American Urological Association (AUA) recognizes PDE5 inhibitors, including tadalafil, as first-line pharmacotherapy for erectile dysfunction [2]. Insurance plans that follow evidence-based guidelines typically include at least one PDE5 inhibitor on their formularies.

Medicaid vs. Medicare Advantage Differences

Gateway's legacy book included both Medicaid managed care and Medicare Advantage (MA) plans. Medicaid plans in Pennsylvania must cover FDA-approved drugs under federal rebate agreements, though they can impose preferred drug lists and prior authorization [3]. MA plans have more flexibility to exclude specific drugs or require step therapy. Your explanation of benefits (EOB) document specifies which category your plan falls into.

Does the Formulary Include Tadalafil or Brand Cialis?

Most UPMC Health Plan formularies list generic tadalafil rather than brand-name Cialis. The FDA approved generic tadalafil in 2018 after Eli Lilly's patent exclusivity expired, and generic entry reduced average wholesale prices by approximately 80% within two years [4]. Plans strongly prefer generics because they deliver identical clinical outcomes at lower cost.

Tier Placement and What It Costs You

Generic tadalafil typically sits on Tier 2 (preferred generic) or Tier 3 (non-preferred generic) depending on the specific UPMC/Gateway plan. Tier 2 copays on Medicaid managed care plans in Pennsylvania range from $1 to $3 per prescription [5]. For MA plans, Tier 2 copays commonly fall between $5 and $20, while Tier 3 may run $30 to $50.

Brand Cialis, when listed at all, lands on Tier 4 or the specialty tier. A 30-day supply of brand Cialis 20 mg can exceed $500 without insurance [6]. Even with Tier 4 coverage, your out-of-pocket cost could reach $75 to $150 per fill.

Quantity Limits You Should Expect

Nearly all managed care plans impose quantity limits on ED medications. Common limits include 6 tablets per 30 days for on-demand dosing (10 mg or 20 mg) and 30 tablets per 30 days for daily 5 mg dosing prescribed for BPH or combined ED/BPH [7]. These limits align with FDA-approved dosing schedules. Exceeding the quantity limit requires a prior authorization showing medical necessity.

Prior Authorization and Step Therapy Requirements

Prior authorization (PA) is the most common barrier members face when filling tadalafil prescriptions for ED. The PA process exists because insurers want confirmation that the drug is medically appropriate, not solely a lifestyle choice. This distinction traces back to how insurers historically classified ED treatments.

What the PA Process Looks Like

Your prescriber submits a PA request to UPMC Health Plan's pharmacy department. The request must include a documented diagnosis of erectile dysfunction (ICD-10 code N52.x), relevant medical history, and any prior treatments attempted [8]. The AUA's 2018 guideline update states that "PDE5 inhibitors are recommended as first-line therapy for the management of erectile dysfunction" [2]. Because tadalafil is itself first-line, some plans approve it without requiring a trial of another PDE5 inhibitor first.

Other plans use step therapy. Step therapy means you must try and fail sildenafil (generic Viagra) before the plan will cover tadalafil. Sildenafil is often the lowest-cost PDE5 inhibitor on formulary, with generic versions available for under $1 per tablet at some pharmacies [9]. If sildenafil causes unacceptable side effects or proves ineffective, your prescriber documents this to satisfy step therapy requirements.

BPH Coverage: A Different Pathway

The FDA approved tadalafil 5 mg daily for BPH in 2011 [10]. When prescribed for BPH (ICD-10 code N40.x), prior authorization criteria differ. Many plans cover daily tadalafil for BPH without requiring a PDE5 inhibitor step-therapy sequence because the condition is urological, not sexual. A meta-analysis of 11 randomized controlled trials (N=3,053) found that tadalafil 5 mg daily improved International Prostate Symptom Scores (IPSS) by a mean of 2.1 points versus placebo [11].

If you have both ED and BPH, a single tadalafil 5 mg daily prescription may treat both conditions. Dr. Kevin McVary, a urologist and lead author of AUA BPH guidelines, has noted: "Tadalafil occupies a unique position as the only PDE5 inhibitor approved for both ED and BPH, making it a practical monotherapy option for men with both conditions" [12].

How to Check Your Specific Coverage

Plan documents vary by enrollment year, county, and plan tier. Checking your exact coverage takes about 10 minutes.

Three Ways to Verify

First, log into the UPMC Health Plan member portal and search the formulary tool for "tadalafil." The tool returns tier placement, quantity limits, and any PA or step therapy flags. Second, call the member services number on the back of your insurance card. Ask specifically: "Is generic tadalafil covered on my formulary, and does it require prior authorization for erectile dysfunction?" Third, ask your pharmacist to run a test claim. A test claim shows real-time adjudication, including copay amount and any rejection codes.

Reading Your Explanation of Benefits

Your EOB lists covered drug categories. Look for "urological agents" or "erectile dysfunction agents." Some Medicaid managed care plans in Pennsylvania list ED drugs under a carve-out benefit, meaning a separate pharmacy benefit manager handles them [5]. If your EOB references a carve-out, contact the carve-out PBM directly for formulary details.

What to Do If Coverage Is Denied

A denial is not the end of the road. Federal and state regulations give you the right to appeal, and appeal success rates for prescription drug denials range from 40% to 60% depending on the strength of clinical documentation [13].

The Internal Appeal Process

File an internal appeal within 60 days of the denial notice. Your prescriber should submit a letter of medical necessity explaining why tadalafil is required over formulary alternatives. Include any relevant lab work (testosterone levels, hemoglobin A1c if diabetic), a history of failed alternative treatments, and citations from clinical guidelines. The Endocrine Society's 2018 guideline for testosterone therapy notes that ED evaluation should include assessment of PDE5 inhibitor candidacy as standard practice [14].

External Review Rights

If the internal appeal fails, Pennsylvania law allows you to request an external review through an independent review organization (IRO). The IRO's decision is binding on the insurer. For Medicaid members, the Pennsylvania Department of Human Services oversees a fair hearing process that operates separately from the plan's internal appeals [5].

Patient Assistance as a Backup

Eli Lilly's patient assistance program covers brand Cialis for qualifying uninsured or underinsured patients, but it does not apply to Medicaid or Medicare beneficiaries [15]. For generic tadalafil, GoodRx and RxAssist list cash prices as low as $8 to $15 for a 30-day supply of tadalafil 5 mg daily at major chain pharmacies, which may be cheaper than your plan's copay in some cases.

Cost Comparison: Tadalafil vs. Other Covered ED Medications

Understanding relative costs helps you and your prescriber choose the most affordable option on your specific formulary.

Sildenafil (Generic Viagra)

Generic sildenafil is almost universally Tier 1 or Tier 2. Cash prices run $0.30 to $2.00 per tablet for 20 mg or 100 mg strengths [9]. Onset is 30 to 60 minutes, and duration is 4 to 6 hours. A randomized trial of 532 men found sildenafil 100 mg improved erections sufficient for intercourse in 82% of attempts versus 24% with placebo [16].

Tadalafil (Generic Cialis)

Generic tadalafil offers a longer duration of action (up to 36 hours for on-demand dosing) and the daily dosing option. Cash prices range from $0.50 to $4.00 per tablet depending on strength and pharmacy [6]. The LVHB study (N=348) showed tadalafil 20 mg enabled successful intercourse in 73% of attempts at 24 hours and 59% at 36 hours post-dose [17].

Avanafil (Stendra)

Avanafil is a newer PDE5 inhibitor with faster onset (15 minutes) but shorter duration. It is rarely covered on Medicaid formularies and typically sits on Tier 3 or higher on commercial plans. Cash prices exceed $40 per tablet [6].

Alprostadil (Injection or Urethral)

For patients who cannot use PDE5 inhibitors due to contraindications (concurrent nitrate therapy, for example), alprostadil is an alternative. It requires injection or intraurethral administration. Coverage is more consistent because it serves patients who have failed oral therapy.

Clinical Considerations That Affect Coverage Decisions

Insurers evaluate ED drug coverage through a clinical lens. Certain medical conditions make coverage approval more likely.

Diabetes and ED

Men with type 2 diabetes experience ED at rates two to three times higher than the general population. The Massachusetts Male Aging Study found that diabetes was the strongest single predictor of ED, with complete ED affecting 28% of diabetic men compared to 9.6% of the general cohort [18]. A diabetes diagnosis (ICD-10 E11.x) strengthens prior authorization requests because the ED is clearly secondary to a documented medical condition.

Post-Prostatectomy ED

Nerve-sparing radical prostatectomy causes ED in 25% to 75% of men depending on surgical technique and patient age [19]. The AUA recommends PDE5 inhibitors as first-line rehabilitation therapy after prostatectomy [2]. Plans routinely approve tadalafil for post-surgical ED with minimal pushback.

Cardiovascular Safety

The Princeton III Consensus Panel classifies men with ED into cardiovascular risk categories [20]. Low-risk patients can use PDE5 inhibitors safely. Intermediate-risk patients need cardiac evaluation first. High-risk patients should defer sexual activity until stabilized. This risk stratification framework is the same one insurers reference when evaluating PA requests. Dr. Robert Kloner, a cardiologist who contributed to the Princeton Consensus, stated: "PDE5 inhibitors have a favorable cardiovascular safety profile in appropriately selected patients, and ED itself should be considered a sentinel marker for underlying cardiovascular disease" [20].

Drug Interactions That May Limit Coverage

Tadalafil is absolutely contraindicated with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension [10]. Alpha-blockers used for BPH (tamsulosin, doxazosin) require dose adjustments when combined with tadalafil. If your medication list includes nitrates, the PA will be denied on safety grounds regardless of formulary status.

Switching from Brand Cialis to Generic Tadalafil

If you currently take brand Cialis and your plan stops covering it, switching to generic tadalafil is straightforward. The FDA requires generic drugs to demonstrate bioequivalence, defined as 90% confidence intervals for AUC and Cmax falling within 80% to 125% of the reference product [21]. Generic tadalafil meets this standard. Same drug. Same dose. Same expected effect.

Your prescriber can write a new prescription specifying "tadalafil" without a brand preference, or your pharmacist can automatically substitute the generic unless "dispense as written" is indicated. If you notice any subjective difference after switching, report it to your prescriber, but clinical evidence does not support meaningful differences between brand and generic tadalafil in efficacy or safety [21].